Objective: To compare the trends of partial nephrectomy (PN) and radical nephrectomy (RN) in 2 European tertiary referral centers with regards to guideline changes. Materials and Methods: A total of 1,573 patients who underwent RN or PN for localized (≤T2) renal cell carcinoma (RCC) were included. Logistic regression analyses assessed the predictors of PN and laparoscopy over time. Results: Out of the total, 1,013 patients (65.6%) were treated with RN and 560 patients (34.4 %) with PN. Also, 1,233 patients (80%) had open surgery whereas 340 patients (22%) were treated with a laparoscopic approach. Laparoscopic RN and PN were performed in 216 (13.7%) and 124 (7.8%) patients, respectively. T1b tumors were 73% less likely (p < 0.001) to be treated with PN compared to T1a tumors. The odds of undergoing PN or laparoscopy in 2008-2010 relative to 2000-2001 were 6.5-fold (p < 0.001) and 36-fold higher (p < 0.001), respectively. Conclusions: Tumor size and year of surgery are independent predictors of PN in our cohort. Our data exemplify the adoption of PN for RCC in tertiary care centers in Austria and Germany in line with implemented guideline changes. The utilization of PN has increased over time regardless of surgical approach. Further studies need to address the use of robot-assisted surgery and care in community hospitals.

Keywords:
Partial nephrectomy, Guidelines, Trend analysis, Laparoscopy, Utilization
1.
Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Colombel M, Klotz L, Skinner E, Keane T, Marreaud S, Collette S, Sylvester R: A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-552.
2.
Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF, Sinescu IC: EAU guidelines on renal cell carcinoma: the 2010 update; European Association of Urology Guideline Group. Eur Urol 2010;58:398-406.
3.
Dash A, Vickers AJ, Schachter LR, Bach AM, Snyder ME, Russo P: Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. BJU Int 2006;97:939-945.
4.
Lane BR, Gill IS: 7-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol 2010;183:473-479.
5.
Kim SP, Shah ND, Weight CJ, Thompson RH, Moriarty JP, Shippee ND, Costello BA, Boorjian SA, Leibovich BC: Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort. J Urol 2011;186:1779-1785.
6.
Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC: Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178:41-46.
7.
Gong EM, Orvieto MA, Zorn KC, Lucioni A, Steinberg GD, Shalhav AL: Comparison of laparoscopic and open partial nephrectomy in clinical T1a renal tumors. J Endourol 2008;22:953-957.
8.
Zini L, Patard JJ, Capitanio U, Mejean A, Villers A, de La Taille A, Ficarra V, Crepel M, Bertini R, Salomon L, Verhoest G, Perrotte P, Bensalah K, Arjane P, Biserte J, Montorsi F, Karakiewicz P: The use of partial nephrectomy in European tertiary care centers. Eur J Surg Oncol 2009;35:636-642.
9.
Thorstenson A, Bergman M, Scherman-Plogell AH, Hosseinnia S, Ljungberg B, Adolfsson J, Lundstam S: Tumour characteristics and surgical treatment of renal cell carcinoma in sweden 2005-2010: a population-based study from the national Swedish kidney cancer register. Scand J Urol 2014;48:231-238.
10.
Colli J, Sartor O, Grossman L, Lee BR: Underutilization of partial nephrectomy for stage T1 renal cell carcinoma in the United States, trends from 2000 to 2008. A long way to go. Clin Genitourin Cancer 2012;10:219-224.
11.
Fedeli U, Novara G, Alba N, Ficarra V, Artibani W, Spolaore P: Trends from 1999 to 2007 in the surgical treatments of kidney cancer in Europe: data from the Veneto region, Italy. BJU Int 2010;105:1255-1259.
12.
Kummerlin IP, ten Kate FJ, Wijkstra H, Zwinderman A, de la Rosette JJ, Laguna MP: A decade of surgically removed small renal masses in the Netherlands: characteristics and trends in type of surgery and pathologic reporting. J Endourol 2010;24:1675-1679.
13.
Small AC, Tsao CK, Moshier EL, Gartrell BA, Wisnivesky JP, Godbold J, Sonpavde G, Palese MA, Hall SJ, Oh WK, Galsky MD: Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States. World J Urol 2013;31:1211-1217.
14.
Thompson RH, Kaag M, Vickers A, Kundu S, Bernstein M, Lowrance W, Galvin D, Dalbagni G, Touijer K, Russo P: Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol 2009;181:993-997.
15.
Bianchi M, Becker A, Abdollah F, Trinh QD, Hansen J, Tian Z, Shariat SF, Perrotte P, Karakiewicz PI, Sun M: Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: a population-based evaluation. Int J Urol 2013;20:1064-1071.
16.
Miller DC, Hollingsworth JM, Hafez KS, Daignault S, Hollenbeck BK: Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol 2006;175(3 pt 1):853-857; discussion 858.
17.
Weight CJ, Crispen PL, Breau RH, Kim SP, Lohse CM, Boorjian SA, Thompson RH, Leibovich BC: Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int 2013;111:731-738.
18.
Mickisch G, Carballido J, Hellsten S, Schulze H, Mensink H; European Association of Urology: Guidelines on renal cell cancer. Eur Urol 2001;40:252-255.
19.
Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard JJ, Sinescu IC; European Association of Urology Guideline Group for renal cell carcinoma: Renal cell carcinoma guideline. Eur Urol 2007;51:1502-1510.
20.
Liss MA, Wang S, Palazzi K, Jabaji R, Patel N, Lee HJ, Parsons JK, Derweesh IH: Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses. BMC Urol 2014;14:101.
21.
Bjurlin MA, Walter D, Taksler GB, Huang WC, Wysock JS, Sivarajan G, Loeb S, Taneja SS, Makarov DV: National trends in the utilization of partial nephrectomy before and after the establishment of AUA guidelines for the management of renal masses. Urology 2013;82:1283-1289.
22.
Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr: Rising incidence of renal cell cancer in the United States. JAMA 1999;281:1628-1631.
23.
Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR: Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008;113:78-83.
24.
Abouassaly R, Alibhai SM, Tomlinson G, Timilshina N, Finelli A: Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer. J Urol 2010;183:467-472.
25.
Ouzaid I, Ravery V: Surgical management of kidney cancer in France: overview of the last decade. Eur Urol 2012;62:942-943.
26.
Ficarra V, Rossanese M, Gnech M, Novara G, Mottrie A: Outcomes and limitations of laparoscopic and robotic partial nephrectomy. Curr Opin Urol 2014;24:441-447.
27.
Ghani KR, Sukumar S, Sammon JD, Rogers CG, Trinh QD, Menon M: Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: results from the Nationwide Inpatient Sample. J Urol 2014;191:907-912.
28.
Kobayashi K, Saito T, Kitamura Y, Nobushita T, Kawasaki T, Hara N, Takahashi K: The RENAL nephrometry score and the PADUA classification for the prediction of perioperative outcomes in patients receiving nephron-sparing surgery: feasible tools to predict intraoperative conversion to nephrectomy. Urol Int 2013;91:261-268.
29.
Yasuda Y, Yuasa T, Yamamoto S, Urakami S, Ito M, Sukegawa G, Kitsukawa S, Yonese J, Fukui I: Evaluation of the RENAL nephrometry scoring system in adopting nephron-sparing surgery for cT1 renal cancer. Urol Int 2013;90:179-183.
30.
Ramaswamy K, Kheterpal E, Pham H, Mohan S, Stifelman M, Taneja S, Huang WC: Significance of pathologic T3a upstaging in clinical T1 renal masses undergoing nephrectomy. Clin Genitourin Cancer 2015;13:344-349.
31.
Yaycioglu O, Rutman MP, Balasubramaniam M, Peters KM, Gonzalez JA: Clinical and pathologic tumor size in renal cell carcinoma; difference, correlation, and analysis of the influencing factors. Urology 2002;60:33-38.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.